TALOPH(SH:600222) Zheng Xing Xing Ye Ri Bao·2025-09-10 08:30Market Overview - The Chinese medicine sector experienced a decline of 0.29% on September 10, with Tai Long Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3812.22, up 0.13%, while the Shenzhen Component Index closed at 12557.68, up 0.38% [1] Stock Performance - Notable gainers in the Chinese medicine sector included: - Weikang Pharmaceutical: closed at 21.53, up 5.08% with a trading volume of 53,100 shares and a turnover of 113 million yuan [1] - Guizhou Bai Ling: closed at 11, up 6.05% with a trading volume of 459,500 shares and a turnover of 276 million yuan [1] - Zhongsheng Pharmaceutical: closed at 20.73, up 2.27% with a trading volume of 401,500 shares and a turnover of 841 million yuan [1] - Conversely, Tai Long Pharmaceutical saw a decline of 1.36%, closing at 6.55 with a trading volume of 161,900 shares and a turnover of 106 million yuan [2] Capital Flow - The Chinese medicine sector experienced a net outflow of 225 million yuan from institutional investors, while retail investors saw a net inflow of 118 million yuan [2] - Key stocks with significant capital flow included: - Guizhou Bai Ling: net inflow of 28.80 million yuan from institutional investors, but a net outflow of 28.34 million yuan from retail investors [3] - Kunming Pharmaceutical: net inflow of 27.63 million yuan from institutional investors, with a net outflow of 14.18 million yuan from retail investors [3] - Zhongsheng Pharmaceutical: net inflow of 20.23 million yuan from institutional investors, but a net outflow of 55.71 million yuan from retail investors [3]